PMID: 9005747Jan 15, 1997Paper

Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy

Annals of Internal Medicine
L HarrisonJ Hirsh

Abstract

Loading doses of warfarin that are larger than those used for maintenance therapy are widely used in clinical practice, but they have never been prospectively evaluated. To compare the effect of 5- and 10-mg loading doses of warfarin on laboratory markers of warfarin's anticoagulant effect. Randomized clinical trial. Tertiary care teaching hospital. 49 patients seen over a 5-month period with a target international normalized ratio (INR) of 2.0 to 3.0. Patients were randomly assigned to receive an initial dose of 5 or 10 mg of warfarin. Subsequent doses of warfarin were administered on the basis of dosing nomograms. INRs and levels of factors II, VII, IX, and X and protein C were measured daily for 5 days. 11 of 25 patients in the 10-mg group (44% [95% CI, 34% to 54%]) and 2 of 24 patients in the 5-mg group (8% [CI, 3% to 14%]) had INRs greater than 2.0 at 36 hours (P = 0.005), at which time the factor VII levels were 27% (CI, 18% to 36%) in the 10-mg group and 54% (CI, 43% to 65%) in the 5-mg group (P < 0.001). In contrast, factor II levels were 74% (CI, 67% to 81%) in the 10-mg group and 82% (CI, 73% to 93%) in the 5-mg group (P > 0.2). At 60 hours, 9 of 25 patients in the 10-mg group (36% [CI, 17% to 54%]) and no patients in...Continue Reading

Citations

May 8, 2000·Journal of Clinical Laboratory Analysis·R S RileyL M Fisher
Jun 19, 2013·European Journal of Clinical Pharmacology·Tudor Radu PopAnca Dana Buzoianu
Oct 2, 2007·Journal of Thrombosis and Thrombolysis·Brian F Gage, Lawrence J Lesko
Jul 7, 2009·Journal of Thrombosis and Thrombolysis·M Houman FekrazadDavid Garcia
Apr 17, 2010·Journal of Thrombosis and Thrombolysis·Nancy L DawsonAlden K Valentino
Jan 29, 2011·Journal of Thrombosis and Thrombolysis·Andrea Lee, Mark Crowther
Nov 15, 2011·Journal of Thrombosis and Thrombolysis·Nancy L DawsonAlden V Patel
Nov 15, 2005·Current Treatment Options in Cardiovascular Medicine·Marc Meysman, Patrick Haentjens
Nov 30, 2000·Current Treatment Options in Cardiovascular Medicine·H Al-ZahraniJ I Weitz
Nov 7, 2001·Current Treatment Options in Gastroenterology·Guna Raj, Carmela Morales
Nov 30, 2000·Current Treatment Options in Neurology·S ChaturvediS R Levine
Aug 23, 2001·Thrombosis Research·A Y Lee
Dec 4, 2003·Thrombosis Research·Philip C Comp
Feb 11, 2000·Thrombosis Research·W Ageno
May 14, 2003·Journal of the American College of Cardiology·Jack HirshUNKNOWN American Heart Association/American College of Cardiology Foundation
Apr 12, 2001·European Journal of Internal Medicine·L PinedeJ Ninet
Mar 15, 2002·Journal of the American College of Surgeons·Arash Rafii TabriziBradley D Freeman
Jun 20, 1998·British Journal of Haematology·R C Tait, A Sefcick
Jul 19, 2002·Seminars in Hematology·S Jean Chai, B Gail Macik
May 22, 1997·The New England Journal of Medicine·C Kearon, J Hirsh
Jul 9, 1998·The New England Journal of Medicine·S Z Goldhaber
Aug 15, 2003·The New England Journal of Medicine·Sam Schulman
Feb 27, 1999·Current Opinion in Obstetrics & Gynecology·E C Grendys, J V Fiorica
Jun 23, 2001·The Journal of Cardiovascular Nursing·A M Aquila
Apr 17, 2001·American Journal of Therapeutics·S A Doi
Jul 21, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S-H YooS U Kwon
Sep 23, 1998·Pacing and Clinical Electrophysiology : PACE·D J GoldsteinH M Spotnitz
Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine·T M Hyers
Mar 28, 2007·Blood·Eric A MillicanBrian F Gage
Nov 22, 2007·Current Medical Research and Opinion·Richard J FriedmanUNKNOWN Global Orthopaedic Registry Investigators
Apr 21, 2010·BMC Cardiovascular Disorders·Carl HeneghanAlison Ward
Dec 7, 2007·Journal of Medical Case Reports·Ronan A Cahill, Hp Redmond
Aug 12, 2000·Drugs & Aging·J L Sebastian, D D Tresch
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·J A Heit
Dec 9, 2003·Paediatric Drugs·Milind D RongheNicholas J Goulden
Sep 15, 2005·Clinical Medicine & Research·Michael A HillmanJames K Burmester
May 25, 2012·International Journal of Critical Illness and Injury Science·Sanjith Saseedharan, Sunil Bhargava
Nov 5, 2013·Future Cardiology·Gaurav TyagiRamdas G Pai
May 1, 2007·Future Cardiology·Virginie SiguretIsabelle Gouin-Thibault
Dec 20, 2013·European Heart Journal·Laurent AzoulaySamy Suissa
Dec 22, 2007·Expert Review of Cardiovascular Therapy·Katherine W Phillips, Jack Ansell
Apr 14, 2006·Expert Opinion on Drug Safety·Luke R BereznickiElla C Jeffrey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.